UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The ' what' and ' how ' of screening for social needs in healthcare settings: a scoping review

PeerJ (San Francisco, CA), 2023-04, Vol.11, p.e15263-e15263, Article e15263

2023

Volltextzugriff (PDF)

Exploring the readiness of senior doctors and nurses to assess and address patients' social needs in the hospital setting

BMC health services research, 2022-02, Vol.22 (1), p.246-246, Article 246

2022

Volltextzugriff (PDF)

Smoking and HIV: what are the risks and what harm reduction strategies do we have at our disposal?

AIDS research and therapy, 2018-12, Vol.15 (1), p.26-26, Article 26

2018

Volltextzugriff (PDF)

Correction to: Exploring the readiness of senior doctors and nurses to assess and address patients' social needs in the hospital setting

BMC health services research, 2022-03, Vol.22 (1), p.359-359, Article 359

2022

Volltextzugriff (PDF)

Preventing empirical antibiotic treatment failure in migrant populations: screening by infection risk, not ethnic background

International journal of infectious diseases, 2023-09, Vol.134, p.168-171

2023

Volltextzugriff (PDF)

Impact of health literacy and its interventions on health outcomes in those with atrial fibrillation: a systematic review protocol

BMJ open, 2022-12, Vol.12 (12), p.e065407

2022

Volltextzugriff (PDF)

Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection

Frontiers in immunology, 2021-05, Vol.12, p.688886-688886

2021

Volltextzugriff (PDF)

Capturing the social determinants of health at the individual level: a pilot study

Public Health Research & Practice, 2021-06, Vol.31 (2)

2021

Volltextzugriff (PDF)

Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study

PLoS medicine, 2017-11, Vol.14 (11), p.e1002424-e1002424

2017

Volltextzugriff (PDF)

The clinical utility of the urine-based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: an observational study

BMC medicine, 2017-08, Vol.15 (1), p.145-145, Article 145

2017

Volltextzugriff (PDF)

Efficacy and safety of contemporary dual-drug antiretroviral regimens as first-line treatment or as a simplification strategy: a systematic review and meta-analysis

The lancet HIV, 2016-08, Vol.3 (8), p.e351-e360

2016

Volltextzugriff (PDF)

Development of recommendations for a minimum dataset for Identifying Social factors that Stratify Health Opportunities and Outcomes (ISSHOOs) in pain research

MethodsX, 2024-06, Vol.12, p.102496, Article 102496

2024

Volltextzugriff (PDF)

Sociodemographic, lifestyle and metabolic predictors of all-cause mortality in a cohort of community-dwelling population: an 18-year follow-up of the North West Adelaide Health Study

BMJ open, 2019-08, Vol.9 (8), p.e030079-e030079

2019

Volltextzugriff (PDF)

Barriers to digital health services among people living in areas of socioeconomic disadvantage: Research from hospital diabetes and antenatal clinics

Health promotion journal of Australia, 2022-07, Vol.33 (3), p.751-757

2022

Volltextzugriff (PDF)

Raltegravir non-inferior to nucleoside based regimens in second-line therapy with lopinavir/ritonavir over 96 weeks: a randomised open label study for the treatment of HIV-1 infection

PloS one, 2015-02, Vol.10 (2), p.e0118228-e0118228

2015

Volltextzugriff (PDF)

Optimisation of HIV care and service delivery: doing more with less

The Lancet (British edition), 2012-11, Vol.380 (9856), p.1860-1866

2012

Volltextzugriff (PDF)

Antiretroviral regimens sparing agents from the nucleoside(tide) reverse transcriptase inhibitor class: a review of the recent literature

AIDS research and therapy, 2013-12, Vol.10 (1), p.33-33

2013

Volltextzugriff (PDF)

Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis

The lancet HIV, 2015-02, Vol.2 (2), p.e42-e51

2015

Volltextzugriff (PDF)

Exploring self-determined solutions to service and system challenges to promote social and emotional wellbeing in Aboriginal and Torres Strait Islander people: a qualitative study

Frontiers in public health, 2023-09, Vol.11, p.1206371-1206371

2023

Volltextzugriff (PDF)

Rates and factors associated with major modifications to first-line combination antiretroviral therapy: results from the Asia-Pacific region

PloS one, 2013-06, Vol.8 (6), p.e64902-e64902

2013

Volltextzugriff (PDF)

Investigating potential transmission of antimicrobial resistance in an open-plan hospital ward: a cross-sectional metagenomic study of resistome dispersion in a lower middle-income setting

Antimicrobial resistance & infection control, 2021-03, Vol.10 (1), p.56-56, Article 56

2021

Volltextzugriff (PDF)

Inflammatory biomarkers and soft tissue changes among patients commencing second-line antiretroviral therapy after first-line virological failure

AIDS (London), 2021-11, Vol.35 (14), p.2289-2298

2021

Volltextzugriff (PDF)

Moving away from Ritonavir, Abacavir, Tenofovir, and Efavirenz (RATE)--agents that concern prescribers and patients: a feasibility study and call for a trial

PloS one, 2014-06, Vol.9 (6), p.e99530

2014

Volltextzugriff (PDF)

Correction: Raltegravir Non-Inferior to Nucleoside Based Regimens in SECOND-LINE Therapy with Lopinavir/Ritonavir over 96 Weeks: A Randomised Open Label Study for the Treatment Of HIV-1 Infection

PloS one, 2015-10, Vol.10 (10), p.e0140623-e0140623

2015

Volltextzugriff (PDF)

HIV lipodystrophy in participants randomised to lopinavir/ritonavir (LPV/r) +2-3 nucleoside/nucleotide reverse transcriptase inhibitors (N(t)RTI) or LPV/r + raltegravir as second-line antiretroviral therapy

PloS one, 2013, Vol.8 (10), p.e77138

2013

Volltextzugriff (PDF)

1 – 25 von 2.573

Suche als RSS-Feed

Aktive Filter

PublikationsformTagungsberichte

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.030)
Mit Volltextzugriff
(2.114)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.398)
Life Sciences & Biomedicine
(1.126)
Humans
(834)
Female
(442)
Male
(402)
Biological And Medical Sciences
(321)
Adult
(264)
Middle Aged
(264)
Medical Sciences
(252)
Animals
(220)
Aged
(189)
Physical Sciences
(177)
Infectious Diseases
(159)
General & Internal Medicine
(123)
Immunology
(111)
Technology
(104)
Mice
(103)
Medicine, General & Internal
(101)
Public, Environmental & Occupational Health
(95)
Risk Factors
(94)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

The ' what' and ' how ' of screening for social needs in healthcare settings: a scoping review

Exploring the readiness of senior doctors and nurses to assess and address patients' social needs in the hospital setting

Smoking and HIV: what are the risks and what harm reduction strategies do we have at our disposal?

Correction to: Exploring the readiness of senior doctors and nurses to assess and address patients' social needs in the hospital setting

Preventing empirical antibiotic treatment failure in migrant populations: screening by infection risk, not ethnic background

Impact of health literacy and its interventions on health outcomes in those with atrial fibrillation: a systematic review protocol

Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection

Capturing the social determinants of health at the individual level: a pilot study

Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study

The clinical utility of the urine-based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: an observational study

Efficacy and safety of contemporary dual-drug antiretroviral regimens as first-line treatment or as a simplification strategy: a systematic review and meta-analysis

Development of recommendations for a minimum dataset for Identifying Social factors that Stratify Health Opportunities and Outcomes (ISSHOOs) in pain research

Sociodemographic, lifestyle and metabolic predictors of all-cause mortality in a cohort of community-dwelling population: an 18-year follow-up of the North West Adelaide Health Study

Barriers to digital health services among people living in areas of socioeconomic disadvantage: Research from hospital diabetes and antenatal clinics

Raltegravir non-inferior to nucleoside based regimens in second-line therapy with lopinavir/ritonavir over 96 weeks: a randomised open label study for the treatment of HIV-1 infection

Optimisation of HIV care and service delivery: doing more with less

Antiretroviral regimens sparing agents from the nucleoside(tide) reverse transcriptase inhibitor class: a review of the recent literature

Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis

Exploring self-determined solutions to service and system challenges to promote social and emotional wellbeing in Aboriginal and Torres Strait Islander people: a qualitative study

Rates and factors associated with major modifications to first-line combination antiretroviral therapy: results from the Asia-Pacific region

Investigating potential transmission of antimicrobial resistance in an open-plan hospital ward: a cross-sectional metagenomic study of resistome dispersion in a lower middle-income setting

Inflammatory biomarkers and soft tissue changes among patients commencing second-line antiretroviral therapy after first-line virological failure

Moving away from Ritonavir, Abacavir, Tenofovir, and Efavirenz (RATE)--agents that concern prescribers and patients: a feasibility study and call for a trial

Correction: Raltegravir Non-Inferior to Nucleoside Based Regimens in SECOND-LINE Therapy with Lopinavir/Ritonavir over 96 Weeks: A Randomised Open Label Study for the Treatment Of HIV-1 Infection

HIV lipodystrophy in participants randomised to lopinavir/ritonavir (LPV/r) +2-3 nucleoside/nucleotide reverse transcriptase inhibitors (N(t)RTI) or LPV/r + raltegravir as second-line antiretroviral therapy

Aktive Filter

Suchergebnisse filtern